Proper pharmacy management requires a juggling of multiple disciplines along with a strong grasp of the entire medication use process. It is a marriage of clinical and scientific approaches with business acumen and leadership skills. Thus, effective management involves learning from and leaning on others, particularly those facing similar challenges and who have found any manner of process improvement.
Although no pharmacy operation is the same, most share at least some commonalities, along with the universal desire to provide safe, consistent care to patients. This is why Pharmacy Purchasing & Products casts such a wide net in its coverage of hospital pharmacy practices. We have grown ourselves, from early coverage of basic pharmacy tools and services to more sophisticated and nuanced subjects, such as how to limit drug diversion (see the supplement) and how to train staff on the differences between hazardous drugs and hazardous waste. Given the rapid evolution that marks these issues, many pharmacies can benefit from the successful programs of their peers. This is a central goal at PP&P: Find ways to help pharmacy thought leaders help each other.
In addition to the above-mentioned articles, we also share our periodic Ask the Expert feature with Patricia Kienle, RPh, MPA, director of accreditation and medication safety at Cardinal Health. Patti is a well-known and highly knowledgeable advocate for safe medication practices and has served on multiple initiatives to improve the safety and efficacy of pharmacy practices. We discuss with Patti steps to identify gaps in USP <800> compliance and gain a valuable foothold in achieving this forthcoming requirement.
As always, we encourage you to remain up to date with your free subscription. Visit www.pppmag.com/subscribe today; it only takes a few moments to ensure you and your pharmacy staff and future leaders can benefit from the seasoned experience of your colleagues.
All the best,
R. Mitchell Halvorsen
Correction: Due to an editing error in our February 2021 issue, the article “COVID-19 Vaccination Storage and Supply Chain Strategies” (page 8) incorrectly stated that the undiluted Pfizer-BioNTech vaccine can be stored between 20˚ and 80˚C for up to 120 hours, and between 20˚ to 25˚C following dilution for up to 6 hours. The article should have read that the undiluted Pfizer-BioNTech vaccine can be stored between 2˚ and 8˚C for up to 120 hours to allow for thawing. Following dilution, the vaccine can be stored between 2˚ to 25˚C and must be used within 6 hours. We sincerely regret this mistake.